![Michael Bo Pålsson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Bo Pålsson
Vorstandsvorsitzender bei Upfront Chromatography A/S
Profil
Michael Bo Pålsson is currently the Chief Executive Officer & Director at Upfront Chromatography A, Director at Bioneer A, and Director at Appium Partners.
Previously, he held positions as the Chief Executive Officer at Chempaq A, Chairman at BONESUPPORT HOLDING AB, Director at Neurodan A, and Director at Vivostat A from 2007 to 2010.
In 2016, he briefly served as the Chief Operating Officer at Bioporto A.
Mr. Pålsson obtained his undergraduate degree from Copenhagen Business School and Technical University of Denmark.
Aktive Positionen von Michael Bo Pålsson
Unternehmen | Position | Beginn |
---|---|---|
Upfront Chromatography A/S
![]() Upfront Chromatography A/S Miscellaneous Commercial ServicesCommercial Services Upfront Chromatography A/S develops a customized protein separation process. The firm offers industrial-scale customized separation solutions to isolate and purify soluble proteins from industrial process streams. Its core protein purification technology, rhobust, is applicable to industrial feed stocks. The company was founded by Allan Otto Fog Lihme in 1992 and is headquartered in Copenhagen, Denmark. | Vorstandsvorsitzender | - |
Bioneer A/S
![]() Bioneer A/S Pharmaceuticals: MajorHealth Technology Bioneer A/S develops and manufactures drugs. The firm's products and services drug development, molecular histology, dynamic gastric model, biomarkers and drug targets, protein manufacturing, mammalian cell technology, immune targeting, active ingredients and microorganisms. The company was founded in 2003 and is headquartered in Horsholm, Denmark. | Direktor/Vorstandsmitglied | - |
Appium Partners | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Michael Bo Pålsson
Unternehmen | Position | Ende |
---|---|---|
BIOPORTO A/S | Geschäftsführer | 12.09.2016 |
Chempaq A/S
![]() Chempaq A/S Medical SpecialtiesHealth Technology Chempaq was formed in 2001 by Ulrik Larsen who is the founder, based on Larsen idea to redefine the hematology test by creating a single use self contained cassette module. This PAQ (cassette) was designed to be easy to use automatically calibrated and to deliver high accuracy and precision. In February 2005, the Chempaq XBC was CE marked. Later in the same year in December, the Chempaq XBC received a 510(k) clearance from the FDA. Since 2005, Doctors offices and Hospitals have provided patients with a unique infection diagnosis using the Chempaq XBC product. | Präsident | 03.08.2011 |
Vivostat A/S
![]() Vivostat A/S Medical SpecialtiesHealth Technology Vivostat A/S provides cardiac, thoracic and orthopaedic surgery medical devices. It offers vivostat system, an automated system for the on-site preparation and application of patient-derived fibrin sealant or platelet rich fibrin. Its products include Vivostat autologous fibrin sealant for various settings in surgical areas, transfusion centers, or blood banks and Vivostat platelet rich fibrin, which utilizes the patient's own blood to derive either a surgical sealant to prevent and stop bleedings, or a gel with a high concentration of growth factors that stimulates the healing of chronic wounds, as well as provides application devices. The compnay was founded in 2001 by Tom Bjerg Lauritzen and Niels Hvid and is headquartered in Alleroed, Denmark. | Vorsitzender | - |
Neurodan A/S
![]() Neurodan A/S Medical SpecialtiesHealth Technology Neurodan A/S develops and commercializes sensory and motor-neuro stimulation medical devices. It manufactures medical implantable devices which restore functionality to patients with central nerve damage through the application of Functional Electrical Stimulation (FES) and Neuro-Muscular Electrical Stimulation (NMES). The company was founded by Thomas Sinkjær and Morten Haugland in 1994 and is headquartered in Aalborg, Denmark. | Direktor/Vorstandsmitglied | - |
BONESUPPORT HOLDING AB | Vorsitzender | - |
Ausbildung von Michael Bo Pålsson
Technical University of Denmark | Undergraduate Degree |
Copenhagen Business School | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
BONESUPPORT HOLDING AB | Health Technology |
BIOPORTO A/S | Health Technology |
Private Unternehmen | 6 |
---|---|
Chempaq A/S
![]() Chempaq A/S Medical SpecialtiesHealth Technology Chempaq was formed in 2001 by Ulrik Larsen who is the founder, based on Larsen idea to redefine the hematology test by creating a single use self contained cassette module. This PAQ (cassette) was designed to be easy to use automatically calibrated and to deliver high accuracy and precision. In February 2005, the Chempaq XBC was CE marked. Later in the same year in December, the Chempaq XBC received a 510(k) clearance from the FDA. Since 2005, Doctors offices and Hospitals have provided patients with a unique infection diagnosis using the Chempaq XBC product. | Health Technology |
Neurodan A/S
![]() Neurodan A/S Medical SpecialtiesHealth Technology Neurodan A/S develops and commercializes sensory and motor-neuro stimulation medical devices. It manufactures medical implantable devices which restore functionality to patients with central nerve damage through the application of Functional Electrical Stimulation (FES) and Neuro-Muscular Electrical Stimulation (NMES). The company was founded by Thomas Sinkjær and Morten Haugland in 1994 and is headquartered in Aalborg, Denmark. | Health Technology |
Vivostat A/S
![]() Vivostat A/S Medical SpecialtiesHealth Technology Vivostat A/S provides cardiac, thoracic and orthopaedic surgery medical devices. It offers vivostat system, an automated system for the on-site preparation and application of patient-derived fibrin sealant or platelet rich fibrin. Its products include Vivostat autologous fibrin sealant for various settings in surgical areas, transfusion centers, or blood banks and Vivostat platelet rich fibrin, which utilizes the patient's own blood to derive either a surgical sealant to prevent and stop bleedings, or a gel with a high concentration of growth factors that stimulates the healing of chronic wounds, as well as provides application devices. The compnay was founded in 2001 by Tom Bjerg Lauritzen and Niels Hvid and is headquartered in Alleroed, Denmark. | Health Technology |
Upfront Chromatography A/S
![]() Upfront Chromatography A/S Miscellaneous Commercial ServicesCommercial Services Upfront Chromatography A/S develops a customized protein separation process. The firm offers industrial-scale customized separation solutions to isolate and purify soluble proteins from industrial process streams. Its core protein purification technology, rhobust, is applicable to industrial feed stocks. The company was founded by Allan Otto Fog Lihme in 1992 and is headquartered in Copenhagen, Denmark. | Commercial Services |
Bioneer A/S
![]() Bioneer A/S Pharmaceuticals: MajorHealth Technology Bioneer A/S develops and manufactures drugs. The firm's products and services drug development, molecular histology, dynamic gastric model, biomarkers and drug targets, protein manufacturing, mammalian cell technology, immune targeting, active ingredients and microorganisms. The company was founded in 2003 and is headquartered in Horsholm, Denmark. | Health Technology |
Appium Partners |